Credit Suisse Starts Durata Therapeutics (DRTX) at Outperform

August 14, 2012 7:19 AM EDT
Get Alerts DRTX Hot Sheet
Price: $24.16 --0%

Rating Summary:
    5 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
Credit Suisse initiates coverage on Durata Therapeutics (NASDAQ: DRTX) with a Outperform. PT $13.00.

For an analyst ratings summary and ratings history on Durata Therapeutics click here. For more ratings news on Durata Therapeutics click here.

Shares of Durata Therapeutics closed at $7.86 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Credit Suisse